We have heard some arguments here today that, if H.R. 3 were to become law, then there is a likelihood that innovation would be driven to China. I think that this is a red herring, let's be clear, because absolutely nothing in H.R. 3 is closing the U.S. market for drug manufacturers or drug development.
Dingell argues against claims that H.R. 3 would harm U.S. drug innovation.
Share
More from Debbie Dingell
There are two words that sum up what Republicans are doing: chaos and corruption.
As a staunch defender of Michigan's auto industry, which is still the backbone of the American economy, and someone who cares deeply about the environment, I do not take this vote lightly. I have spoken multiple times to all of the…
No person should have to decide whether they pay their water bill or buy groceries.
Other voices in this conversation
